CN1739595A - Dangshen oral liquid - Google Patents

Dangshen oral liquid Download PDF

Info

Publication number
CN1739595A
CN1739595A CN 200510012819 CN200510012819A CN1739595A CN 1739595 A CN1739595 A CN 1739595A CN 200510012819 CN200510012819 CN 200510012819 CN 200510012819 A CN200510012819 A CN 200510012819A CN 1739595 A CN1739595 A CN 1739595A
Authority
CN
China
Prior art keywords
radix codonopsis
dangshen
oral liquid
proportion
props
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200510012819
Other languages
Chinese (zh)
Inventor
叶美曾
郭小玲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200510012819 priority Critical patent/CN1739595A/en
Publication of CN1739595A publication Critical patent/CN1739595A/en
Pending legal-status Critical Current

Links

Landscapes

  • Filtering Materials (AREA)

Abstract

The Dangshen oral liquid has the effective part extract of Dangshen and the effective part extract is prepared with Dangshen and through crushing, twice or thrice decoction in water of 7-10 times for 2-3 hr each, filtering to obtain filtrate, decompression concentrating to obtain the concentrated effective part extract. The Dangshen oral liquid has specific weight of 1.10-1.20 measured at 70-80 deg.c, contains Dangshen polysaccharide in 5-15 % and is packed in glass bottle, plastic bottle or aluminum foil bag in 10-30 ml each.

Description

Dangshen oral liquid
Technical field
The present invention is a kind of preparation dangshen oral liquid of Radix Codonopsis effective part extract preparation.
Technical background
The Chinese crude drug Radix Codonopsis is traditional tcm clinical first-selection, be invigorating the spleen and replenishing QI, spleen invigorating lung benefiting, strengthening the body resistance, strengthening by means of tonics and antidotal key medicine, be applicable to all cards of deficiency of both the splenic and pulmonary QI, many Chinese and overseas scholars have carried out extensive studies with regard to its kind, plant, pharmacology and each side such as clinical, confirm that Radix Codonopsis has many-sided pharmacological action, be made into the soft extract dosage form, be used for clinical.
In the prior art, traditional water alcohol method preparation technology, the asiabell effective ingredient glycocalix is used as " impurity " and is removed, and most of Radix Codonopsis polysaccharide composition is dropped behind precipitate with ethanol, affect the treatment, and alcohol precipitation process consumption alcohol amount is big.
In addition, commercially available Radix codonopsis pilosulae's oral liquid (the accurate word Z20059002 of traditional Chinese medicines), though with the Radix Codonopsis polysaccharide is to indicate component, carries the secondary alcohol precipitation process because of adopting water, causes the asiabell effective ingredient polysaccharide to be lost in a large number, with its Radix Codonopsis polysaccharide content of high-pressure liquid phase chromatogram therapy determining only about 1%, press Radix Codonopsis clinical treatment radiacmeter, take 10-15 at every turn and prop up, 2 times on the one, need 20-30 to prop up, just can reach therapeutic dose.
Summary of the invention
It is low to the present invention is directed to the Radix Codonopsis asiabell effective ingredient polyoses content that exists in the prior art, the technical problem of weak curative effect, the dangshen oral liquid that provides a kind of Radix Codonopsis active ingredient Radix Codonopsis polysaccharide content to make at Radix Codonopsis polysaccharide extract's concentrated solution of 5-15%.
The present invention realizes by following technical proposal:
Dangshen oral liquid is characterized in that being made by following method:
Step 1, the preparation method of Radix Codonopsis effective site Radix Codonopsis polysaccharide extract concentrated solution;
A, dedusting are cleaned: with the raw material Radix Codonopsis decontamination and the medicine that goes mouldy, flushing with clean water;
B, chopping:, be cut into the section of 2-4cm with codonopsis pilosula;
C, decoction: with the Radix Codonopsis section that cuts, put into Decocting pot and decoct, add the pure water that 7-10 doubly measures, decoct 2-3 time, each 2-3 hour, filter merging filtrate;
D, concentrated: the filtrate of merging, being evaporated to proportion is 1.10-1.20, temperature is 70-80 ℃ and records;
Step 2 prepares dangshen oral liquid with Radix Codonopsis effective site Radix Codonopsis polysaccharide extract concentrated solution;
A, be taken at temperature 70-80 ℃ and record, proportion is 1.10-1.20; Content is Radix Codonopsis polysaccharide extract's concentrated solution of 5-15%;
B, be that 10-30ml/ props up, be loaded in washed glass bottle, plastic bottle or the aluminium foil bag and seal sterilization promptly according to the cubage loading amount.
The proportion of dangshen oral liquid extract of the present invention is 1.10-1.11,70 ℃ of surveys, and it is 5-8% that high pressure lipuid chromatography (HPLC) records Radix Codonopsis polysaccharide content, loading amount is that 18-30ml/ props up, and is sub-packed in washed glass bottle, plastic bottle or the aluminium foil bag and seals sterilization promptly.
The proportion of dangshen oral liquid extract of the present invention is 1.11-1.15,75 ℃ of surveys, and high-pressure liquid phase chromatogram therapy determining Radix Codonopsis polysaccharide content is 8-11%, loading amount is that 15-20ml/ props up, and is sub-packed in washed glass bottle, plastic bottle or the aluminium foil bag and seals sterilization promptly.
The proportion of dangshen oral liquid extract of the present invention is 1.15-1.20,80 ℃ of surveys, high-pressure liquid phase chromatogram therapy determining Radix Codonopsis polysaccharide content is 11-15%, and loading amount is that 10-15ml/ props up, and is sub-packed in washed glass bottle, plastic bottle or the aluminium foil bag and seals sterilization promptly.
Technical scheme of the present invention is patent of invention " preparation method of a kind of Radix Codonopsis effective site and preparation Radix Codonopsis soft extract thereof " (this invention patent applied for the inventor, application number 200410012172.7, patent publication No. CN1559500A) the dangshen oral liquid preparation that development increases on the basis, physicochemical property according to the Radix Codonopsis effective part extract, take extraction process by water, effective site and active component group with codonopsis pilosula are all kept, and are prepared into the oral liquid of various content.The advantage accurate according to oral liquid formulations dosage, that the loading amount size is easily flexible has designed oral liquid effective site Radix Codonopsis polysaccharide content 5-15%, and all size dangshen oral liquid of loading amount 10-30ml is to satisfy clinical and demand market.
Advantage of the present invention and beneficial effect:
1, Radix Codonopsis effective site Radix Codonopsis polysaccharide and other effective part groups are all water-soluble, and Radix Codonopsis polysaccharide is insoluble to alcohol, and the extract that water extraction process obtains can keep the property of medicine of crude drug Radix Codonopsis;
2, the total sugar content of Radix Codonopsis is up to about 40%, and all the other are fructose and a small amount of glucose, sucrose to its component except that Radix Codonopsis polysaccharide, boil through decocting and are concentrated into debita spissitudo, can obtain meeting the oral liquid of regulation under the Chinese Pharmacopoeia mixture item;
3, the present invention is not with chemical preservative, the effective site Radix Codonopsis polysaccharide content that has guaranteed Radix Codonopsis is the pure natural medical preparation up to 15%, has kept peculiar fragrance, sweet, the steady quality of flavor of codonopsis pilosula, take safe ready, guaranteed curative effect, accepted by child and women easily;
4, the oral liquid taking dose is little, and it is accurate that the liquid preparation branch is got dosage, and the dosage size is easily flexible, and according to the requirement of clinical treatment dosage, but packing dosage is 10-30ml, and control, packing dosage are unit dose package easily, are convenient to take, carry and store.One of unit dose package can reach clinical treatment dosage, is sub-packed in vial, plastic bottle or the aluminium foil bag.
The specific embodiment
Embodiment 1, and preparation Radix Codonopsis polysaccharide content is 5%, and the branch loading amount is the oral liquid that 30ml/ props up;
Step 1 is extracted the Radix Codonopsis effective part extract, and this extract can obtain with following method, get the Radix Codonopsis raw medicinal material 100kg that quality standard meets, dedusting is cleaned, and the raw material Radix Codonopsis is removed impurity and the thing flushing with clean water of going mouldy, be chopped into the 2-4cm section, add the 700kg decocting and boil 2-3 time, each 2-3 hour, filter, merging filtrate, heavy clear, be evaporated to proportion 1.10-1.11,70 ℃ of concentrated solutions that record promptly get the Radix Codonopsis effective part extract.
Step 2 is got the concentrated solution of step 1 preparation, and high-pressure liquid phase chromatogram therapy determining Radix Codonopsis polysaccharide content is 5%, this extracting solution is sub-packed in washed glass bottle, plastic bottle or the aluminium foil bag seals sterilization, the branch loading amount is that 30ml/ props up instructions of taking: each 1, and every day 2 times.
Embodiment 2, and preparation Radix Codonopsis polysaccharide content is 10%, and the branch loading amount is the dangshen oral liquid that 15ml/ props up;
Step 1 is extracted the Radix Codonopsis effective part extract, and this extract can obtain with following method, get the Radix Codonopsis raw medicinal material 100kg that quality standard meets, dedusting is cleaned, and the raw material Radix Codonopsis is removed impurity and the thing flushing with clean water of going mouldy, be chopped into the 2-4cm section, add the 700kg decocting and boil 2-3 time, each 2-3 hour, filter, merging filtrate, heavy clear, be evaporated to proportion 1.110-1.115,75 ℃ of concentrated solutions that record promptly get the Radix Codonopsis effective part extract;
Get the concentrated solution of step 1 preparation, high-pressure liquid phase chromatogram therapy determining Radix Codonopsis polysaccharide content is 10%, this extracting solution is sub-packed in washed glass bottle, plastic bottle or the aluminium foil bag seals sterilization, and the branch loading amount is that 15ml/ props up instructions of taking: each 1, and every day 2 times.
Embodiment 3, and preparation Radix Codonopsis polysaccharide content is 15%, and the branch loading amount is the dangshen oral liquid that 10ml/ props up;
Step 1 is extracted the Radix Codonopsis effective part extract, and this extract can obtain with following method, get the Radix Codonopsis raw medicinal material 100kg that quality standard meets, dedusting is cleaned, and the raw material Radix Codonopsis is removed impurity and the thing flushing with clean water of going mouldy, be chopped into the 2-4cm section, add the 700kg decocting and boil 2-3 time, each 2-3 hour, filter, merging filtrate, heavy clear, be evaporated to proportion 1.115-1.200,80 ℃ of concentrated solutions that record promptly get the Radix Codonopsis effective part extract;
Get the concentrated solution of step 1 preparation, high-pressure liquid phase chromatogram therapy determining Radix Codonopsis polysaccharide content is 15%, this extracting solution is sub-packed in washed glass bottle, plastic bottle or the aluminium foil bag seals sterilization, and the branch loading amount is that 10ml/ props up instructions of taking: each 1, and every day 2 times.

Claims (4)

1, a kind of dangshen oral liquid is characterized in that being made by following method:
Step 1, the preparation method of Radix Codonopsis effective site Radix Codonopsis polysaccharide extract concentrated solution;
A, dedusting are cleaned: with the raw material Radix Codonopsis decontamination and the medicine that goes mouldy, flushing with clean water;
B, chopping:, be cut into the section of 2-4cm with codonopsis pilosula;
C, decoction: with the Radix Codonopsis section that cuts, put into the decoction cylinder and decoct, add the pure water that 7-10 doubly measures, decoct 2-3 time, each 2-3 hour, filter merging filtrate;
D, concentrated: the filtrate of merging, being evaporated to proportion is 1.10-1.20, temperature is 70-80 ℃ and records;
Step 2 prepares dangshen oral liquid with Radix Codonopsis effective site Radix Codonopsis polysaccharide extract concentrated solution;
A, be taken at temperature 70-80 ℃ and record, proportion is 1.10-1.20; Content is Radix Codonopsis polysaccharide extract's concentrated solution of 5-15%;
B, be that 10-30ml/ props up, be loaded in washed glass bottle, plastic bottle or the aluminium foil bag and seal sterilization promptly according to the cubage loading amount.
2, dangshen oral liquid according to claim 1, it is characterized in that extracting solution proportion is 1.10-1.11,70 ℃ of surveys, it is 5-8% that high pressure lipuid chromatography (HPLC) records Radix Codonopsis polysaccharide content, loading amount is that 18-30ml/ props up, and is sub-packed in washed glass bottle, plastic bottle or the aluminium foil bag and seals sterilization promptly.
3, according to the described dangshen oral liquid of claim 1, it is characterized in that extracting solution proportion is 1.11-1.15,75 ℃ of surveys, high-pressure liquid phase chromatogram therapy determining Radix Codonopsis polysaccharide content is 8-11%, loading amount is that 15-20ml/ props up, and is sub-packed in washed glass bottle, plastic bottle or the aluminium foil bag and seals sterilization promptly.
4, according to the described dangshen oral liquid that gets of claim 1, it is characterized in that extract proportion is 1.15-1.20,80 ℃ of surveys, high-pressure liquid phase chromatogram therapy determining Radix Codonopsis polysaccharide content is 11-15%, loading amount is that 10-15ml/ props up, and is sub-packed in washed glass bottle, plastic bottle or the aluminium foil bag and seals sterilization promptly.
CN 200510012819 2005-09-13 2005-09-13 Dangshen oral liquid Pending CN1739595A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200510012819 CN1739595A (en) 2005-09-13 2005-09-13 Dangshen oral liquid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200510012819 CN1739595A (en) 2005-09-13 2005-09-13 Dangshen oral liquid

Publications (1)

Publication Number Publication Date
CN1739595A true CN1739595A (en) 2006-03-01

Family

ID=36092220

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200510012819 Pending CN1739595A (en) 2005-09-13 2005-09-13 Dangshen oral liquid

Country Status (1)

Country Link
CN (1) CN1739595A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102525901A (en) * 2012-01-19 2012-07-04 江西新世纪民星动物保健品有限公司 Animal codonopsis pilosula polysaccharide oral solution and preparation method thereof
CN106176878A (en) * 2016-07-11 2016-12-07 周晗生 The extracting method of Radix Codonopsis extract

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102525901A (en) * 2012-01-19 2012-07-04 江西新世纪民星动物保健品有限公司 Animal codonopsis pilosula polysaccharide oral solution and preparation method thereof
CN102525901B (en) * 2012-01-19 2013-10-30 江西新世纪民星动物保健品有限公司 Animal codonopsis pilosula polysaccharide oral solution and preparation method thereof
CN106176878A (en) * 2016-07-11 2016-12-07 周晗生 The extracting method of Radix Codonopsis extract

Similar Documents

Publication Publication Date Title
CN100374120C (en) Powder of flenabane and its preparation method as well as application in making drugs
US9278948B2 (en) Line leaf inula flower lactone A and methods for preparing and using the same for treating multiple sclerosis
CN1723981A (en) Novel use of extractive of Momordica grosvenori as adjuvant drug for preparing medicine
CN1739595A (en) Dangshen oral liquid
CN1883673A (en) Compound preparation of pseudostellaria root and preparation method thereof
CN107266599B (en) Flammulina velutipes, extracting method and its application in terms of functional consitipation drug is treated in preparation
CN101045153A (en) Traditional Chinese medicine for treating cold
CN1887324A (en) Chinese composition and its prepn process and quality control method
CN1300164C (en) Method for extracting vitexin, use and preparation
CN1309367C (en) Preparation of Chinese traditional medicine for curing gallstone and preparation method
CN1309368C (en) Preparation of Chinese traditional medicine for curing cough and preparation method
CN102429994A (en) Compound heartleaf houttuynia herb mixture and preparation method thereof
CN102641342A (en) Traditional Chinese medicine extract for treating nephropathy and preparation method
CN1861127A (en) Compound lobelia oral liquid prepn. and its prepn. method
CN101745011B (en) Method for extracting ginseng, dwarf lilyturf tuber and schisandra chinensis and preparation thereof
CN101474185A (en) Western medicine compound preparation for resisting cardiovascular disease and preparation method thereof
CN101745016B (en) Extraction method of 'ginseng/radix ophiopogonis and schisandra chinensis' and preparation thereof
CN1060051C (en) Anti-cancer compn. and prepn. thereof
CN115737729B (en) Ethnic medicine preparation for treating osteoporosis and preparation method thereof
CN1224411C (en) Freeze-dried powder injection for curing hepatitis, large dise transfusion medicine and its preparation method
CN1053817C (en) Acanthopanax root injection freeze-dried powder injection and producing technology for acanthopanax root extract
CN1600357A (en) Effective position of pilose asiabell root, preparation, medication use and preparation method
CN1456230A (en) Preparation of six component rehmannia root pills
CN1958584A (en) Derivative of fibrauretine, and preparation method
CN101745004B (en) Method for extracting radix ophiopogonis, ginseng and schisandra chinensis as well as preparation thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication